Loading
Diagnos Inc Stock: price and insider trades · Canada
CA·Mcap CA$56.3M
Diagnos Inc: what insiders have been doing
This page follows insider dealings at Diagnos Inc as filed with SEDI. The last twelve months, up to 18 October 2026, brought 26 filings signed by 6 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 8 purchases totalling €119k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 senior executives. One trade stands out by size: a purchase of €37k from Dunn, Robert, disclosed on 31 July 2026, or 0.10% of market capitalisation.
Across the 2,120 companies tracked on its exchange, the median is 12 filings; at 26 filings, this issuer sits above that mark. Over the whole record (from 2026), the tally stands at 8 purchases and no sales.
The last insider purchase was made public on 28 August 2026, 50 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 1 day. The shorter that gap, the sooner other investors can see what insiders have done.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
26
Thresholds
n/a
Buy Volume
€118,633
8 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMichael Braeuel6 buys
Robert Dunn2 buys
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended March 2026 · cache
CA$0.47
Analyst consensus
Income statement
RevenueCA$65.5k
Gross profitCA$10k15% margin
EBITDA-CA$4M-6170% margin
Net income-CA$4.6M-6956.8% margin
Valuation
P/Book77.5x
Beta0.08
Balance sheet & cash
Market capCA$56.3M
Total debtCA$1.4M
Free Cash Flow-CA$3.8M
Debt / Equity204%
Profitability & ownership
ROE-990.3%
ROA-88.4%
% insiders5.4%
% institutions0.0%
Last declaration on 28 August 2026
Declarations26 total
105,000 shares@ CA$0.4750.086% mcap16.7% of flowCommon SharesTSXSEDI:4769786
Canonical exit: 26 Nov 2026 (T+90)
100,000 shares@ CA$0.400.069% mcap13.4% of flowCommon SharesTSXSEDI:4767850
100,000 sharesWarrantsTSXSEDI:4767848
166,666 shares@ CA$0.400.11% mcap15.1% of flowWarrantsTSXSEDI:4766627
270,270 shares@ CA$0.3722.7% of flowCommon SharesTSXSEDI:4766623
@ €0.2295Convertible Debentures 10% $0.37 Exp May 18 2027TSXSEDI:4766620
@ €0.1743Convertible Debentures 10% 05-09-2026 $0.28TSXSEDI:4765594
357,142 shares@ CA$0.2833.5% of flowCommon SharesTSXSEDI:4765592
50,000 shares@ CA$0.39120.034% mcap4.5% of flowCommon SharesTSXSEDI:4765253
Canonical exit: 15 Nov 2026 (T+90)
50,000 shares@ CA$0.3850.033% mcap4.4% of flowCommon SharesTSXSEDI:4765251
Canonical exit: 15 Nov 2026 (T+90)
357,143 shares@ CA$0.400.24% mcap32.2% of flowWarrantsTSXSEDI:4759812
25,000 shares@ CA$0.280.012% mcap1.6% of flowCommon SharesTSXSEDI:4757393
Canonical exit: 28 Oct 2026 (T+90)
25,000 shares@ CA$0.2850.012% mcap1.6% of flowCommon SharesTSXSEDI:4757392
Canonical exit: 28 Oct 2026 (T+90)
50,000 shares@ CA$0.28260.024% mcap3.2% of flowCommon SharesTSXSEDI:4757391
Canonical exit: 28 Oct 2026 (T+90)
53,571 shares@ CA$0.28320.026% mcap3.4% of flowCommon SharesTSXSEDI:4757389
Canonical exit: 28 Oct 2026 (T+90)
200,000 shares@ CA$0.2950.10% mcap19.7% of flowCommon SharesTSXSEDI:4757309
Canonical exit: 27 Oct 2026 (T+90)
250,000 shares@ CA$0.2016.7% of flowOptionsTSXSEDI:4734699
250,000 shares@ CA$0.2011.3% of flowOptionsTSXSEDI:4734698
300,000 shares@ CA$0.20100.0% of flowOptionsTSXSEDI:4734697
300,000 shares@ CA$0.20100.0% of flowOptionsTSXSEDI:4734696
200,000 shares@ CA$0.20100.0% of flowOptionsTSXSEDI:4734690
200,000 shares@ CA$0.20100.0% of flowOptionsTSXSEDI:4734674
75,000 sharesOptionsTSXSEDI:4734673
50,000 sharesOptionsTSXSEDI:4734048
100,000 sharesOptionsTSXSEDI:4734047
25 of 26 declarations
About Diagnos Inc
Diagnos Inc is a company focused on developing artificial intelligence solutions for medical diagnostics. It is listed on the XTSE market.
